3654 results for «382»
3654 results
Tricuspid regurgitation: a new prospect in the management of patients with TR
15 Dec 2022 – From GulfPCR-GIM 2022
Thanks to this GulfPCR-GIM 2022 session, get to understand how the TricValve can help in the management of patients with functional TR, know more about the TricValve Bicaval Valves system, and gain insight into the early adoption experience in the Middle East.
Optimising immediate and long-term outcomes after TAVI
15 Dec 2022 – From GulfPCR-GIM 2022
This session focuses on the use of the Acurate Neo2 valve in daily practice: watch it if you wish to learn how to determine clinical scenarios where the valve in question would be the best option, to find out more about lifetime management of AS patients...
Another frontier crossed!
15 Dec 2022 – From GulfPCR-GIM 2022
Watch this session to find out more about the optimal approach to complex patients, to learn about optimal plaque modification techniques, including atherectomy, to discuss the approach to severely calcified lesions, and to know more about the added value of intravascular imaging.
Managing a high bleeding risk patient undergoing PCI
15 Dec 2022 – From GulfPCR-GIM 2022
In this GulfPCR-GIM 2022 session, analyse the cases of a 76-year-old female patient with asthma, angina on exertion, multiple calcific tandem lesions in the LAD and LCX, and minimal RCA disease, and of a 48-year-old male patient, smoker, with ACS in 2012 and 2020, who presented with...
Stable CAD - Tools, devices and techniques
14 Dec 2022 – From GulfPCR-GIM 2022
In this GulfPCR-GIM 2022 session, 3 cases of stent loss are presented, as well as a remote robotic DK Crush in a 3D printed anatomy, and an onion-shaped stent layer in an in-stent restenosis patient.
Challenging CTO Cases - Session 1
14 Dec 2022 – From GulfPCR-GIM 2022
In this GulfPCR-GIM 2022 session, learn about a complex challenging case of left main bifurcation disease and ostial left anterior descending CTO, as well as a rotational atherectomy assisted-PCI for an old calcified CTO, and more!
Challenging TAVI scenarios
14 Dec 2022 – From GulfPCR-GIM 2022
This GulfPCR-GIM 2022 session is for you if you want to learn more about recurrent valve migration during TAVR or TAVI with permanent pacemaker implantation, among others!
Challenging CTO cases - Session 2
14 Dec 2022 – From GulfPCR-GIM 2022
This GulfPCR-GIM 2022 session compiles 5 challenging CTO cases and explains how to handle them. Study for example a flush ostial RCA-CTO, PWS in a CTO feeding vessel, rotablation and intravascular lithotripsy in three-vessel disease with IVUS, or rotaburr incarceration.
POPular PAUSE TAVI - Continuation or interruption of oral anticoagulation during TAVI?
02 Sep 2024
Luis Ortega-Paz provides his take on the POPular PAUSE TAVI trial presented by Dirk Jan van Ginkel at the ESC Congress 2024 in London.
Author
OPTIMUM: Outcomes of Percutaneous RevascularizaTIon for Management of SUrgically Ineligible Patients with Multivessel or Left Main Coronary Artery Disease
04 Nov 2021
Mirvat Alasnag reviews the OPTIMUM trial, presented by David E. Kandzari, which reports outcomes in a subset of patients who are increasingly seen in modern day catheterization laboratories. It is noteworthy that 1 in 5 patients with left main or multivessel disease are considered surgically ineligible.
Author
Best of #AHA21 Scientific Sessions: coronary and valvular heart disease trials
14 Nov 2021
Vijay Kunadian provides summaries of study designs and findings in Interventional Cardiology released at the 2021 virtual edition of the American Heart Association Congress. View an infographic of the AVATAR late-breaking trial by Ali Nazmi Calik.
Author
Evidence base: current data on TAVI durability and long-term outcomes
18 Jun 2026
This article reviews the current evidence on TAVI durability, focusing on long-term outcomes, device-specific considerations, and the implications for lifetime management strategies.
Author
Author
ESC/EACTS Valvular Heart Disease Guidelines 2021: updates from the 2017 Guidelines
29 Aug 2021
There has been significant expansion in the field of structural heart diseases in the last couple of years, generating an extensive body of evidence and warranting an update to the 2017 Guidelines. Mirvat Alasnag provides an analysis of the updates included in this new document - a joint...
Author
Early intervention in patients with asymptomatic severe aortic stenosis and left ventricular myocardial fibrosis (EVOLVED)
30 Oct 2024
Ali Nazmi Calik provides his take on the EVOLVED trial presented by Marc Dweck at TCT 2024 in Washington.
Author
